首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   14240篇
  免费   1171篇
  国内免费   44篇
耳鼻咽喉   102篇
儿科学   436篇
妇产科学   426篇
基础医学   1813篇
口腔科学   343篇
临床医学   1450篇
内科学   2814篇
皮肤病学   119篇
神经病学   1473篇
特种医学   478篇
外科学   2101篇
综合类   317篇
一般理论   26篇
预防医学   1439篇
眼科学   267篇
药学   954篇
中国医学   51篇
肿瘤学   846篇
  2021年   103篇
  2020年   93篇
  2019年   157篇
  2018年   156篇
  2017年   129篇
  2016年   142篇
  2015年   201篇
  2014年   242篇
  2013年   462篇
  2012年   608篇
  2011年   709篇
  2010年   381篇
  2009年   370篇
  2008年   695篇
  2007年   744篇
  2006年   790篇
  2005年   779篇
  2004年   775篇
  2003年   763篇
  2002年   778篇
  2001年   252篇
  2000年   268篇
  1999年   293篇
  1998年   193篇
  1997年   160篇
  1996年   135篇
  1995年   175篇
  1994年   132篇
  1993年   152篇
  1992年   270篇
  1991年   232篇
  1990年   203篇
  1989年   197篇
  1988年   226篇
  1987年   197篇
  1986年   187篇
  1985年   204篇
  1984年   216篇
  1983年   152篇
  1982年   185篇
  1981年   162篇
  1980年   143篇
  1979年   150篇
  1978年   137篇
  1977年   127篇
  1976年   94篇
  1975年   111篇
  1974年   123篇
  1973年   107篇
  1971年   93篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Breast Cancer Research and Treatment - The NSABP B-36 compared four cycles of doxorubicin and cyclophosphamide (AC) with six cycles of 5-fluorouracil, epirubicin, and cyclophosphamide (FEC-100) in...  相似文献   
3.
The EORTC QLU‐C10D is a new multi‐attribute utility instrument derived from the widely used cancer‐specific quality of life questionnaire, EORTC QLQ‐C30. It contains 10 dimensions (physical functioning, role functioning, social functioning, emotional functioning, pain, fatigue, sleep, appetite, nausea, bowel problems), each with four levels. The aim of this study was to provide U.K. general population utility weights for the QLU‐C10D. A U.K. online panel was quota‐sampled to align the sample to the general population proportions of sex and age (≥18 years). The online valuation survey included a discrete choice experiment (DCE). Each participant was asked to complete 16 choice‐pairs, each comprising two QLU‐C10D health states plus duration. DCE data were analysed using conditional logistic regression to generate utility weights. Data from 2,187 respondents who completed at least one choice set were included in the DCE analysis. The final U.K. QLU‐C10D utility weights comprised decrements for each level of each health dimension. For nine of the 10 dimensions (all except appetite), the expected monotonic pattern was observed across levels: Utility decreased as severity increased. For the final model, consistent monotonicity was achieved by merging inconsistent adjacent levels for appetite. The largest utility decrements were associated with physical functioning and pain. The worst possible health state (the worst level of each dimension) is ?0.083, which is considered slightly worse than being dead. The U.K.‐specific utility weights will enable cost–utility analysis (CUA) for the economic evaluation of new oncology therapies and technologies in the United Kingdom, where CUA is commonly used to inform resource allocation.  相似文献   
4.
Bulletin of Environmental Contamination and Toxicology - Aqueous exposures to selenomethionine (SeMet), the major form of selenium (Se) in the diet, represent a rapid and simplified method for...  相似文献   
5.
ABSTRACT

Objectives: The consequences of polypharmacy (intake of ≥ 5 drugs) are diverse, including drug interactions, rising costs and side effects. Risk groups for polypharmacy are multimorbid and chronically ill people, such as patients with multiple sclerosis (MS). MS is the most common neuroimmunological disease in young adults worldwide. We aimed to provide a systematic overview of the current research status regarding frequency and predictors of polypharmacy in MS patients.

Methods: A systematic literature search in the databases PubMed, Cochrane Library and Scopus was carried out according to the PRISMA guidelines. English and German original research articles were included.

Results: Seven studies fulfilled the inclusion criteria of this review, while the research objectives and methods were very heterogenous. The polypharmacy rates in these studies ranged from 15% to 59%. Polypharmacy correlated with comorbidities, increased disability, cognitive deficits, increased hospitalization, higher relapse rate and lower quality of life.

Conclusions: In MS patients, polypharmacy is common and closely associated with health issues. There is a great need for research in this area, especially regarding longitudinal changes in drug utilization. Effective networks between physicians and pharmacists are needed to optimize medication management for patients and to achieve the best possible therapy results.  相似文献   
6.
7.
8.
9.
Cognitive Therapy and Research - Despite interest in psychological inflexibility as a marker of suicide risk, no measure of psychological inflexibility specific to SI exists. The present study...  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号